The Challenge of pediatric acute myeloid leukemia - a precise personalized approach
Grant Amount: NIS 4.875 million
About the Project
Leukemia is the most common childhood cancer. While there has been great progress in curing children from leukemia, many children still succumb to this disease. Our ultimate aim is to cure every child with leukemia. Towards this goal we need to understand the basis for drug resistance of the leukemias subtypes that currently are incurable. We plan to use advanced genomic tools, focusing on single cell sequencing, to identify the precise road map of resistant leukemia evolution and to discover novel targets for therapy.
Research Team
Dr. Yosef Maruvka
Biotechnology and Food Engineering, Technion
Prof. Shai Izraeli
Director of the Rina Zaizov Pediatric Hematology Oncology Division, Schneider Children's Medical Center of Israel
More Projects Funded